Key Figures Q3 2020

SEK m, unless otherwise stated

2020

Jul-Sep

2019

Jul-Sep

2020

Jan-Sep

2019

Jan-Sep

2019

Jan-Dec

2019-2020

Jul-Sep Δ

Net revenues

150.3

231.2

504.4

606.7

844.8

-35%

Cost of goods sold

-14.5

-25.9

-54.3

-82.5

-105.6

-44%

Operating expenses

-165.4

-99.4

-459.0

-364.5

-508.0

66%

EBIT

-29.6

105.9

-8.9

159.7

231.2

-128%

EBIT margin, %

-19.7

45.8

-1.8

26.3

27.4

-65,5 ppt

EBITDA

-12.2

114.1

17.9

186.3

272.1

-111%

Earnings per share, before dilution, SEK

-2.45

3.22

-1.00

5.21

6.33

-137%

Earnings per share, after dilution, SEK

-2.45

3.16

-1.00

5.10

6.20

-138%

Cash flow from operating activities

-12.9

135.7

28.0

230.7

287.0

-110%

Cash and cash equivalents

593.3

812.9

593.3

812.9

816.8

-27%

Net revenues and EBIT per segment Q3 2020

SEK m

                               Revenues

                                   EBIT

 

2020

Jul-Sep

2019

Jul-Sep

2020

Jan-Sep

2019

Jan-Sep

2019

Jan-Dec

2020

Jul-Sep

2019

Jul-Sep

2020

Jan-Sep

2019

Jan-Sep

2019

Jan-Dec

ZUBSOLV® US

143.8

182.7

480.2

528.7

719.2

-

-

-

-

-

US Pharma – total

143.8

182.7

480.2

528.7

719.2

72.4

90.9

237.2

242.6

347.1

Digital Therapeutics

-

-

-

-

-

-62.5

-

-110.1

-

-0.9

Digital Therapeutics– total

-

-

-

-

-

-62.5

-

-110.1

-

-0.9

Abstral® royalties

2.5

42.4

14.6

66.3

112.6

-

-

-

-

-

Edluar® royalties

4.0

6.1

9.5

10.2

11.6

-

-

-

-

-

ZUBSOLV® - ex US

-

-

0.1

0.1

0.1

-

-

-

-

-

OX-MPI

-

0.1

-

1.4

1.4

-

-

-

-

-

HQ & Pipeline

segment – total

6.5

48.6

24.2

78.0

125.6

-39.5

15.0

-136.0

-82.9

-115.0

Total

150.3

231.2

504.4

606.7

844.8

-29.6

105.9

-8.9

159.7

231.2

Cash flow Q3 2020

 

SEK m

2020

Jul-Sep

2019

Jul-Sep

2020

Jan-Sep

2019

Jan-Sep

2019

Jan-Dec

Cash flow from operating activities

-12.9

135.7

28.0

230.7

287.0

Investment activities

-50.2

-14.5

160.9

-15.3

-22.4

Financing activities

-4.2

-36.9

-106.9

-49.4

-53.7

Cash flow (excl exchange rate differences)

-67.4

84.3

-239.1

166.0

210.8

Liquid funds

593.3

812.9

593.3

812.9

816.8